- Clinical Trials
- April 2025
- 40 Pages
Global
From €1097EUR$1,250USD£949GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €2194EUR$2,500USD£1,898GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1097EUR$1,250USD£949GBP
- Clinical Trials
- April 2025
- 550 Pages
Global
From €4388EUR$5,000USD£3,797GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1755EUR$2,000USD£1,519GBP
- Clinical Trials
- April 2025
- 90 Pages
Global
From €1316EUR$1,500USD£1,139GBP
- Report
- October 2024
- 134 Pages
North America
From €2984EUR$3,400USD£2,582GBP
€3510EUR$4,000USD£3,037GBP
- Report
- January 2025
Latin America
From €7460EUR$8,500USD£6,454GBP
- Report
- August 2019
- 488 Pages
Global
From €3510EUR$3,999USD£3,037GBP
- Report
- February 2024
- 468 Pages
Global
From €4212EUR$4,799USD£3,644GBP
- Report
- December 2022
- 425 Pages
Global
From €4725EUR$5,572USD£3,950GBP
- Report
- November 2022
- 154 Pages
Global
From €4388EUR$5,000USD£3,797GBP
- Report
- April 2024
- 270 Pages
Global
From €4388EUR$5,000USD£3,797GBP
- Report
- February 2022
- 272 Pages
Global
From €5266EUR$6,000USD£4,556GBP
- Report
- November 2021
- 222 Pages
Global
From €2633EUR$3,000USD£2,278GBP
- Report
- July 2021
- 60 Pages
Global
From €1755EUR$2,000USD£1,519GBP
- Drug Pipelines
- June 2020
- 34 Pages
Global
From €3072EUR$3,500USD£2,658GBP
- Drug Pipelines
- November 2018
- 47 Pages
Global
From €3072EUR$3,500USD£2,658GBP
- Report
- August 2024
- 80 Pages
Japan
From €2611EUR$2,975USD£2,259GBP
€3072EUR$3,500USD£2,658GBP
- Report
- June 2024
- 183 Pages
Global
From €3357EUR$3,825USD£2,905GBP
€3949EUR$4,500USD£3,417GBP

The Oncogene market is a subset of the Genomics market that focuses on the study of cancer-causing genes. Oncogenes are genes that have the potential to cause cancer when they are mutated or expressed at high levels. Oncogenes are studied to understand the molecular basis of cancer and to develop new treatments. Research in this field has led to the development of targeted therapies, such as monoclonal antibodies, small molecule inhibitors, and gene therapies.
The Oncogene market is highly competitive, with many companies developing new technologies and treatments. Companies in the market include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, and Bio-Rad Laboratories. Show Less Read more